Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/20204367

Download in:

View as

General Info

PMID
20204367